Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Skin Lesion Measurement of Tedizolid in Skin Infections
NCT01519778Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2012
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tedizolid in cutaneous abscess, cellulitis, erysipelas, sponsored by Merck & Co.. Started Feb 2012; status: completed.
02
Drugs
tedizolid
03
Conditions
cutaneous abscesscellulitiserysipelas
Beyond the preview
Go deeper on NCT01519778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01519778.